Interdisciplinary, Delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3).
J Affect Disord May 16, 2026 Peer reviewed DOI: 10.1016/j.jad.2026.121970 via PubMed
Summary
Consensus guidelines have been developed for the use of intravenous ketamine infusions in treating depressive disorders, based on input from a diverse group of experts through a Delphi process. These guidelines aim to standardize practices among healthcare providers in this field.
Study at a glance
| Design | consensus guidelines |
|---|---|
| Key finding | Interdisciplinary consensus guidelines were established for intravenous ketamine infusions for depressive disorders. |
Abstract
Interdisciplinary, Delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3).